Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E2FZ
|
||||
| Former ID |
DIB005599
|
||||
| Drug Name |
ICA-69673
|
||||
| Synonyms |
ICA-069673; Ion channel modulators (epilepsy), ICAgen; Ion channel modulators, ICAgen/ArQule
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Preclinical | [546904] | ||
| Company |
Icagen Inc
|
||||
| Canonical SMILES |
c1(ncc(cn1)NC(=O)c1ccc(c(c1)F)F)Cl
|
||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily KQT member 3 | Target Info | Modulator | ||
| Potassium voltage-gated channel subfamily KQT member 2 | Target Info | Modulator | |||
| KEGG Pathway | Cholinergic synapsehsa04725:Cholinergic synapse | ||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| References | |||||